Frequency of Hyponatremia in Patients With Decompensated Chronic Liver Disease Presenting at Tertiary Care Hospital

Aisha  Bibi; Wasil  Khan; Muhammad  Asim; Maria  Hilal; Irum  Hazrat; . Abdullah

doi:10.54112/bcsrj.v6i7.2146

Authors

Aisha Bibi Department of Medicine, Saidu Group of Teaching Hospital, Pakistan
Wasil Khan Department of Medicine, Saidu Group of Teaching Hospital, Pakistan
Muhammad Asim Department of Medicine, Khalifa Gul Nawaz Teaching Hospital Bannu, Pakistan
Maria Hilal Department of Radiology, RMI, Peshawar, Pakistan
Irum Hazrat Department of Medicine, Saidu Group of Teaching Hospital, Pakistan
. Abdullah Department of Medicine, Saidu Group of Teaching Hospital, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i7.2146

Keywords:

Hyponatremia, decompensated chronic liver disease, cirrhosis, socioeconomic factors, prevalence, electrolyte imbalance.

Abstract

Hyponatremia is a frequent electrolyte disturbance in decompensated chronic liver disease and is linked with worse clinical outcomes. Local estimates help guide early detection and supportive management in tertiary-care settings. Objective: To determine the frequency of hyponatremia in patients with decompensated chronic liver disease presenting at tertiary care hospital. Methods: This study was conducted on 86 patients diagnosed with decompensated chronic liver disease, determined on abdominal ultrasound as coarse parenchymal echogenicity, irregular margins, and ascites, along with complaints such as Fever (>101°F or 38.3°C), abdominal pain (VAS > 3), and fatigue. Patients with flapping tremors and cardiac diseases were excluded. Hyponatremia was assessed in all patients, defined as serum sodium level < 130 mmol/L. SPSS 25 was used for analysis. Results: In the present study, the mean age of the patients was 53.06 ± 13.69 years, gender wise males were in majority 60 (69.8%). Mean serum sodium level was 134.51 ± 7.21 mmol/L. Hyponatremia was observed in 26 patients (30.2%). Conclusion: Hyponatremia is a significant complication in the patients with decompensated chronic liver disease, it was present in 30.2% patients.

Downloads

Download data is not yet available.

References

Cheemerla S, Balakrishnan M. Global epidemiology of chronic liver disease. Clin Liver Dis (Hoboken). 2021;17(5):365–370. https://doi.org/10.1002/cld.1117

Kardashian A, Serper M, Terrault N, Nephew LD. Health disparities in chronic liver disease. Hepatology. 2023;77(4):1382–1403. https://doi.org/10.1002/hep.32600

Chowdhury AB, Mehta KJ. Liver biopsy for assessment of chronic liver diseases: a synopsis. Clin Exp Med. 2023;23(2):273–285. https://doi.org/10.1007/s10238-022-00947-z

Ou TY, Nguyen NT, Hoai LN, Bui LT, Chang YM, Abdi AA, et al. Global mortality of chronic liver diseases attributable to hepatitis B virus and hepatitis C virus infections from 1990 to 2019 and projections to 2030. J Infect Public Health. 2024;17:102443. https://doi.org/10.1016/j.jiph.2024.04.027

Tanwar S, Rhodes F, Srivastava A, Trembling PM, Rosenberg WM. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. World J Gastroenterol. 2020;26(2):109. https://doi.org/10.3748/wjg.v26.i2.109

Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C, et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol. 2020;73(4):842–854. https://doi.org/10.1016/j.jhep.2020.06.013

Juanola A, Ma AT, De Wit K, Gananandan K, Roux O, Zaccherini G, et al. Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis. Gut. 2024;73(1):156–165. https://doi.org/10.1136/gutjnl-2023-329923

Mansour D, McPherson S. Management of decompensated cirrhosis. Clin Med (Lond). 2018;18(2):60–65. https://doi.org/10.7861/clinmedicine.18-2-s60

Kim Y, Kim K, Jang I. Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications. Medicine (Baltimore). 2019;98(45):e17862. https://doi.org/10.1097/MD.0000000000017862

Al-Sofyani KA. Prevalence and clinical significance of hyponatremia in pediatric intensive care. J Pediatr Intensive Care. 2019;8(3):130–137. https://doi.org/10.1055/s-0038-1676635

Wu SL, Zheng YX, Tian ZW, Chen MS, Tan HZ. Scoring systems for prediction of mortality in decompensated liver cirrhosis: a meta-analysis of test accuracy. World J Clin Cases. 2018;6(15):995–1006. https://doi.org/10.12998/wjcc.v6.i15.995

Kogiso T, Kobayashi M, Yamamoto K. The outcome of cirrhotic patients with ascites is improved by the normalization of the serum sodium level by tolvaptan. Intern Med. 2017;56(22):2993–3001. https://doi.org/10.2169/internalmedicine.56.8666

Akram M, Ud Din F, Abidin SZU, Jilani G, Saeed MW. Frequency of hyponatremia in decompensated chronic liver disease patients. Prof Med J. 2023;30(6):710–715. https://doi.org/10.29309/TPMJ/2023.30.06.7509

Afridi MAR, Ali Z, Muhammad R, Asghar M, Afridi MF, Alam AB, et al. Hyponatremia and its correlation with hepatic encephalopathy in patients with cirrhosis liver. J Postgrad Med Inst. 2017;31(3):243–246.

Bhardwaj B, Gupta S, Garg S. Hyponatremia in patients with chronic liver diseases. J Cardiovasc Dis Res. 2023;14(1):3055–3060.

Pradeep C, Sindhura G. Prevalence of hyponatremia in chronic liver disease patients and its correlation with the severity of the disease. Int J Sci Stud. 2022;10(1):40–44.

Mumtaz M, Ahmad W, Khan AH. Frequency of hyponatremia in patients of chronic liver disease. Pak J Med Health Sci. 2017;11(4):1214–1216.

Azam MU, Saeed NU, Javed S, Memon MYY, Aftab MA, Shafqat MN, et al. Prevalence of hyponatremia in patients with decompensated chronic liver diseases presenting in a tertiary care hospital. Cureus. 2024;16(9):e68907. https://doi.org/10.7759/cureus.68907